Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Inke S.A

    Client Virtual Booth

    INKE S.A

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    • Aclidinium Bromide

    • Arformoterol Tartrate

    • Clevidipine

    • Formoterol Fumarate

    • Glycopyrronium Bromide

    • Glycopyrronium Tosylate

    • Granisetron

    • Granisetron Hydrochloride

    • Indacaterol Acetate

    • Indacaterol Maleate

    • Olodaterol Hydrochloride

    • Revefenacin

    • Salmeterol Xinafoate

    • Tafamidis

    • Tafamidis Meglumine

    • Tiotropium Bromide

    • Umeclidinium Bromide

    • Vilanterol Trifenatate

    SERVICES

    Key Products KEY SERVICES

    • Micronisation Technology

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Inke RM
    Inke S.A
    Spain_new Flag
    Country
    Country
    Spain
    Address
    Address
    Area Industrial Llobregat, Argent,1 08755 Castellbisbal Barcelona
    Telephone
    Telephone
    +34 936828180
    Client Email
    Email
    jsanchez@inke.es
    Client Website
    Website
    https://www.inke.es/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/inke/
    Twitter
    Twitter
    Contact Info
    Others

    Full View ScreenFull Screen View
    INKE increases its production capacity with the support of ACCIÓ (Generalitat de Catalunya)
    INKE increases its production capacity with the support of ACCIÓ (Generalitat de Catalunya)

    https://www.inke.es/inke-increases-its-production-capacity-with-the-support-of-accio-generalitat-de-catalunya-n-88-en

    PRESS RELEASE
    15 Jan 2024
    Share Share
    Clifford Chance advises on the financing for Keensight Capital’s acquisition of Inke
    Clifford Chance advises on the financing for Keensight Capital’s acquisition of Inke

    https://iberianlawyer.com/clifford-chance-advises-on-the-financing-for-keensight-capitals-acquisition-of-inke/

    IBERIANLAWYER
    21 Jun 2023
    Share Share
    Neuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital
    Neuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital

    https://www.inke.es/neuraxpharm-agrees-on-the-divestment-of-inhalation-api-specialist-inke-to-keensight-capital-n-87-en

    PRESS RELEASE
    27 Apr 2023
    Share Share
    Neuraxpharm announces closing of acquisition of established products from Sanofi
    Neuraxpharm announces closing of acquisition of established products from Sanofi

    https://www.prnewswire.com/news-releases/neuraxpharm-announces-closing-of-acquisition-of-established-products-from-sanofi-301735596.html

    PR NEWSWIRE
    01 Feb 2023
    Share Share
    Neuraxpharm completes its presence in Benelux by opening an affiliate
    Neuraxpharm completes its presence in Benelux by opening an affiliate

    https://www.prnewswire.com/news-releases/neuraxpharm-completes-its-presence-in-benelux-by-opening-an-affiliate-in-brussels-to-cover-belgium-and-luxembourg-301728349.html

    PR NEWSWIRE
    24 Jan 2023
    Share Share
    Neuraxpharm launches European campaign to increase awareness of medical cannabis
    Neuraxpharm launches European campaign to increase awareness of medical cannabis

    https://www.prnewswire.com/news-releases/neuraxpharm-launches-european-campaign-to-increase-awareness-of-medical-cannabis-301652618.html

    PR NEWSWIRE
    19 Oct 2022
    Share Share
    Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi
    Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi

    https://www.prnewswire.com/news-releases/neuraxpharm-to-increase-branded-business-through-upcoming-acquisition-of-established-products-from-sanofi-301584467.html

    PR NEWSWIRE
    12 Jul 2022
    Share Share
    Inke to triple capacity for inhalation API manufacturing
    Inke to triple capacity for inhalation API manufacturing

    https://www.inke.es/leading-inhalation-apis-expert-inke-to-triple-production-capacity-n-85-en

    PRESS RELEASE
    20 Apr 2022
    Share Share
    Leading inhalation APIs expert Inke to triple production capacity
    Leading inhalation APIs expert Inke to triple production capacity

    https://www.prnewswire.com/news-releases/leading-inhalation-apis-expert-inke-to-triple-production-capacity-301528741.html

    PRNEWSWIRE
    20 Apr 2022
    Share Share
    Panaxia & Neuraxpharm: First export of medical cannabis sublingual tab to France
    Panaxia & Neuraxpharm: First export of medical cannabis sublingual tab to France

    https://www.prnewswire.com/news-releases/panaxia-and-neuraxpharm-first-export-of-medical-cannabis-sublingual-tablets-to-france-301466357.html

    PR NEWSWIRE
    24 Jan 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Inke RM

    Formulation & Delivery

    Attending

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search